Search - tctmd.com

Displaying 61 - 80 of 130

Sort: Relevancy | Date

News Conference News AHA 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

Todd Neale

November 17, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

Presentation TCT 2019

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Presenter: Raj Makkar

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

Presentation TCT 2019

Valve Leaflet Thickening and Thrombosis: Definitions, Frequency, Management, and Clinical Importance

Presenter: Lars Sondergaard

September 26, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Daily News

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

Caitlin E. Cox

August 27, 2019

News Daily News

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Caitlin E. Cox

August 21, 2019

News Daily News

TAVR Bleeds Stand Apart From PCI-Related Events

Caitlin E. Cox

August 06, 2019

Presentation TVT 2019

Leaflet Thrombosis in Bioprosthetic Aortic Valves — Prevalence, Clinical Consequences

Presenter: Anna Sannino

June 13, 2019

Presentation TVT 2019

Case Intervention and Outcomes

Presenter: Hasan Jilaihawi

June 12, 2019

Presentation TVT 2019

Anatomic Analysis TTE/TEE and Panel Discussion

Presenter: Rebecca Hahn

June 12, 2019

Presentation TVT 2019

Case Presentation and Clinical Device Discussion

Presenter: Hasan Jilaihawi

June 12, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

Presentation ARCH 2019

Catheter Based Therapies After Surgical Mitral Interventions

Presenter: Alan Zajarias

April 12, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

News Daily News

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Michael O'Riordan

March 13, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

Advertisement

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

TCT 2019 Day Two: Transcatheter Valves, New and Old

Valve Leaflet Thickening and Thrombosis: Definitions, Frequency, Management, and Clinical Importance

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

TAVR Bleeds Stand Apart From PCI-Related Events

Leaflet Thrombosis in Bioprosthetic Aortic Valves — Prevalence, Clinical Consequences

Case Intervention and Outcomes

Anatomic Analysis TTE/TEE and Panel Discussion

Case Presentation and Clinical Device Discussion

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Catheter Based Therapies After Surgical Mitral Interventions

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content